I., Siltelioglu Turan, I., Mammadov, R., Altnkaynak, K., & Kisaoglu, A
The evidence base is anchored by STEP (semaglutide for weight management, The New England Journal of Medicine , 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
It was shown in vitro to inhibit the uptake of potassium into the cells, capable of inducing cell death in high quantities
Delta sleep-inducing peptide (DSIP) spray designed for in vitro research applications studying sleep patterns and circadian receptor mechanisms
At Somerset Medical, we continually explore ways to provide our patients with the most effective, evidence-based care possible
RUO classification means the material is intended for in-vitro research, assay development, and pre-clinical laboratory work not for diagnostic, therapeutic, or human-administration purposes